«Seronegative» myasthenia gravis and antiMuSK positive antibodies: Description of Spanish series;Miastenia gravis «seronegativa» y anticuerpos antiMuSK positivos: Descripción de una serie Española

Medicina Clinica

Volumn 125, Issue 3, 2005, Pages 100-102

  Illa, Isabel ^a   Díaz Manera, Jordi A ^a   Juárez, Cándido ^a   Rojas García, Ricard ^a   Molina Porcel, Laura ^a   Aleu, Aitziber ^a   Pradas, Jesús ^a   Gallardo, Eduard ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Immunotherapy; MuSK; Myasthenia gravis; Seronegative myasthenia; Thymectomy

Indexed keywords

CHOLINESTERASE INHIBITOR; MUSCLE ANTIBODY; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; AUTOANTIBODY; CHOLINERGIC RECEPTOR; MUSK PROTEIN, HUMAN;

ADULT; ANTIBODY DETECTION; ARTICLE; BULBAR PARALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; MALE; MYASTHENIA GRAVIS; RADIOIMMUNOASSAY; THYMECTOMY; ADOLESCENT; AGED; DIPLOPIA; FATIGUE; HOSPITALIZATION; IMMUNOLOGY; LIMB; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; SPAIN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHOLINESTERASE INHIBITORS; COMBINED MODALITY THERAPY; DIPLOPIA; EXTREMITIES; FATIGUE; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; SEVERITY OF ILLNESS INDEX; SPAIN; THYMECTOMY; TREATMENT OUTCOME;

EID: 22944449652     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076937     Document Type: Article

References (19)

1. Lindsrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholina receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976;26:1054-9.
2. Mossman S, Vincent A, Newsom-Davis J. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between. AChR with antibody bound, acetylcholine receptor loss and transmission defect. J Neurol Sci. 1988;84:15-28.
3. Illa I, Rodríguez JL, Grau JM, Juárez C. Anticuerpos antirreceptor de acetilcolina en miastenia grave. Inmunologia. 1988;7:41-6.
4. Blaes F, Beeson D, Plested P, Lang B, Vincent A. IgG from «seronegative» myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor. Ann Neurol. 2000;47:504-10.
5. Scuderi F, Marino M, Colonna L, Mannella F, Evoli A, Provenzano C, et al. Anti-p110 autoantibodies identify a subtype of «seronegative» myasthenia gravis with prominent oculobulbar involvement. Lab Invest. 2002;82:1139-46.
6. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7:365-8.
7. Liynage Y, Hoch W, Beeson D, Vincent A. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve. 2002;25:4-16.
8. Hoch W. Molecular dissection of neuromuscular junction formation. Trends Neurosci. 2003;26:335-7.
9. Lindstrom J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol. 1977;7:36-43.
10. McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004;55:580-4.
11. Jaretzki A III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis with prednisone. Neurology. 2000;55:16-23.
12. Pradas J, Illa I. Factores de predicción de la respuesta al tratamiento de la miastenia gravis con prednisona. Neurologia. 1990;5:11-3.
13. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology. 2003;60:1978-80.
14. Yen JH, Chen WH, Chiu HC, Vincent A. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese. Neurology. 2004;62:2132-2.
15. Gajdos P. Seronegative myasthenia gravis. Rev Neurol (Paris). 2004;160:159-62.
16. Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain. 2003;126:2304-11.
17. Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, et al. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve. 2004;30:55-60.
18. Aragonés JM, Bolívar I, Bonfill X, Bufill E, Mummany A, Alonso F, et al. Myasthenia gravis: a higher than expected incidence in the elderly. Neurology. 2003;60:1024-6.
19. Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, et al. Thymys changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology. 2005;64:536-8.